In today’s COVID-19 environment, more than ever, the myMatrixx team understands how to innovate and adapt to the changing workforce conditions. Our mission, to provide you with the highest level of customized service, has never been more important. We care deeply about our partners and their injured workers, and we are committed to providing you with the comprehensive information and resources you need to make decisions to support and grow your business.
Please use this resource to stay informed on how myMatrixx is addressing COVID-19 and check in often, as this page is updated frequently.
Image
COVID-19 Helpful Resources
Learn what the Coronavirus is, how it started, symptoms, prevention, and more:
COVID-19 Position Paper
myMatrixx View on COVID-19 Vaccination and Workers' Compensation Coverage
myMatrixx Senior VP of Product Development Talks COVID-19 and Workers' Comp with R & I
February 11, 2021
Senior VP of Product Development, Hollie Lamboy discusses with R & I, the long-term staying power of COVID-19 and how it's impacting workers’ compensation.
Learn more
January 2021 COVID-19 Vaccine Update
January 15, 2021
According to the Centers for Disease Control and Prevention, there have been about 21 million known COVID-19 infections in the U.S. since January 2020.
Learn more
myMatrixx Joins Coalition To Lead COVID-19 Vaccine Credential Initiative
January 14, 2021
myMatrixx recently joined a coalition led by Evernorth to ensure that people vaccinated for COVID-19 have immediate access to their vaccination record.
Learn more
New Clinically Speaking Video Discusses COVID-19 Long-Haulers
January 04, 2021
“Long-haulers” are individuals who have been infected by COVID-19 and have recovered from the acute infection, but continue to have lingering symptoms. It’s important to monitor these patients as there’s emerging evidence of ongoing morbidity or chronic suffering from COVID-19.
Learn more
myMatrixx Hosts Virtual Summit on Transportation Safety and COVID-19
December 21, 2020
The transportation industry has played an essential role in the economy since the outbreak of the COVID-19 Pandemic. As a result, workers in this field are facing a number of unique physical and behavioral health challenges that require attention. To foster a productive dialogue on this topic, mymatrixx recently hosted a virtual panel discussion, “Transportation safety and COVID-19,” on Wednesday, December 9th.
Learn more
Second COVID-19 Vaccine Approved Under Emergency Use Authorization
December 21, 2020
The U.S. Food and Drug Administration (FDA) granted an emergency use authorization (EUA) on Dec. 18, 2020, for Moderna’s vaccine to prevent COVID-19.
Learn more
Evernorth’s Dr. Wigneswaran Talks COVID-19 and Herd Immunity
December 21, 2020
There has been a lot of discussion around herd immunity during the course of the pandemic, including some degree of misinformation. In relation to COVID-19, herd immunity refers to the protection that occurs when a sufficient percentage of the population is immune to the disease, whether through natural infection or vaccination.
Learn more
Emergency Use Authorization for the First COVID Vaccine
December 14, 2020
As expected, the U.S. Food and Drug Administration (FDA) followed its independent Vaccines and Related Biological Products Advisory Committee (VRBPAC) recommendation to approve an emergency use authorization (EUA) for the Pfizer/BioNTech COVID-19 vaccine, BNT162b2, on Dec. 11, 2020.
Learn more